Results 81 to 90 of about 189 (144)
Final results from the phase Ia/Ib study of the novel bromodomain and extra-terminal domain inhibitor, BI 894999, in patients with advanced solid tumors or diffuse large B-cell lymphoma. [PDF]
ESMO OpenLauer UM, Awada A, Postel-Vinay S, Shapiro GI, Thieblemont C, Piha-Paul SA, Paik PK, Shepard DR, Docampo LI, Galot R, Rottey S, Sadrolhefazi B, Marzin K, Musa H, Schöffski P. +14 moreeuropepmc +1 more sourceAirborne concentrations and chemical considerations of radioactive ruthenium from an undeclared major nuclear release in 2017. [PDF]
Proc Natl Acad Sci U S A, 2019 Masson O, Steinhauser G, Zok D, Saunier O, Angelov H, Babić D, Bečková V, Bieringer J, Bruggeman M, Burbidge CI, Conil S, Dalheimer A, De Geer LE, de Vismes Ott A, Eleftheriadis K, Estier S, Fischer H, Garavaglia MG, Gasco Leonarte C, Gorzkiewicz K, Hainz D, Hoffman I, Hýža M, Isajenko K, Karhunen T, Kastlander J, Katzlberger C, Kierepko R, Knetsch GJ, Kövendiné Kónyi J, Lecomte M, Mietelski JW, Min P, Møller B, Nielsen SP, Nikolic J, Nikolovska L, Penev I, Petrinec B, Povinec PP, Querfeld R, Raimondi O, Ransby D, Ringer W, Romanenko O, Rusconi R, Saey PRJ, Samsonov V, Šilobritienė B, Simion E, Söderström C, Šoštarić M, Steinkopff T, Steinmann P, Sýkora I, Tabachnyi L, Todorovic D, Tomankiewicz E, Tschiersch J, Tsibranski R, Tzortzis M, Ungar K, Vidic A, Weller A, Wershofen H, Zagyvai P, Zalewska T, Zapata García D, Zorko B. +68 moreeuropepmc +1 more sourceRipretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial. [PDF]
Nat MedHeinrich MC, Jones RL, George S, Gelderblom H, Schöffski P, von Mehren M, Zalcberg JR, Kang YK, Razak AA, Trent J, Attia S, Le Cesne A, Siontis BL, Goldstein D, Boye K, Sanchez C, Steeghs N, Rutkowski P, Druta M, Serrano C, Somaiah N, Chi P, Reichmann W, Sprott K, Achour H, Sherman ML, Ruiz-Soto R, Blay JY, Bauer S. +28 moreeuropepmc +1 more source
